P Rajagopalan to Middle Aged
This is a "connection" page, showing publications P Rajagopalan has written about Middle Aged.
Connection Strength
0.122
-
Long-term effects of kidney donation on renal function and blood pressure in African Americans. Clin J Am Soc Nephrol. 2011 Jun; 6(6):1474-80.
Score: 0.026
-
Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101.
Score: 0.016
-
Phaeohyphomycosis from Exphiala jeanselmei with concomitant Nocardia asteroides infection in a renal transplant recipient: case report and review of the literature. Pharmacotherapy. 1999 Aug; 19(8):995-1001.
Score: 0.012
-
Stratification of mortality risk for renal artery surgery. Am Surg. 1995 Jan; 61(1):45-51.
Score: 0.009
-
Diverticular complications of renal failure. Gastrointest Radiol. 1990; 15(3):259-62.
Score: 0.006
-
FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study. Clin Transplant. 2009 Sep-Oct; 23(5):589-99.
Score: 0.006
-
Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation. Transplantation. 2006 Dec 27; 82(12):1689-97.
Score: 0.005
-
Prevention of acute tubular necrosis after transplantation: effect of pretransplantation volume expansion. South Med J. 1986 Aug; 79(8):972-4.
Score: 0.005
-
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5.
Score: 0.005
-
Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study. Transplantation. 2005 Jul 27; 80(2):244-52.
Score: 0.004
-
Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
Score: 0.004
-
Thromboembolic risk factors in patients undergoing kidney transplant: implication of abnormally short activated partial thromboplastin time. Ann Clin Lab Sci. 2003; 33(4):396-400.
Score: 0.004
-
Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated recovery. Clin Transplant. 2001; 15 Suppl 6:59-61.
Score: 0.003
-
Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group. Transplantation. 1999 Nov 15; 68(9):1288-94.
Score: 0.003
-
Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation. 1999 Jan 27; 67(2):276-84.
Score: 0.003
-
The effects of prostaglandin E1 on hepatic allograft vascular inflow: a prospective randomized double-blind study. Am Surg. 1996 Mar; 62(3):184-7.
Score: 0.002
-
Treatment of thrombosed dialysis access grafts: randomized trial of surgical thrombectomy versus mechanical thrombectomy with the Amplatz device. J Vasc Interv Radiol. 1996 Mar-Apr; 7(2):185-92.
Score: 0.002
-
Stress steroids are not required for patients receiving a renal allograft and undergoing operation. J Am Coll Surg. 1995 May; 180(5):532-6.
Score: 0.002
-
New patterns of transplant nephrectomy in the cyclosporine era. J Am Coll Surg. 1994 Jan; 178(1):59-64.
Score: 0.002
-
Liver transplantation in South Carolina. J S C Med Assoc. 1993 Mar; 89(3):111-8.
Score: 0.002
-
Renal transplantation in Alport's syndrome. Am Surg. 1985 Jul; 51(7):414-7.
Score: 0.001